Teriflunomide vs injectable disease modifying therapies for relapsing forms of MS.

Multiple sclerosis (MS) is a chronic, immune-mediated, inflammatory disease affecting the white and gray matter of the central nervous system. Several disease modifying therapies (DMTs) have been shown to significantly reduce relapse rates, slow disability worsening, and modify the overall disease course of MS. Decision-making when initiating a DMT should be shared between the patient and physician.

Awareness of stroke risk factors, symptoms, and treatment is poor in people at highest risk.

We designed this study to determine factors associated with community stroke knowledge that could be used to improve education strategies. A survey was mailed to random adult residents of Olmsted County, Minnesota. The questions assessed knowledge of stroke (definition, treatment, symptoms, and risk factors) and access to and attitudes toward health care.